igg4 การใช้
- It is a human IgG4 anti-PD-1 monoclonal antibody.
- It is now regarded as a manifestation of IgG4-related disease.
- The efficacy of alpha blockers in IgG4-related prostatitis remains unclear.
- Normally the IgG4 is considered inert and doesn t elicit an immune response.
- When performing experiments another humanized IgG4 class antibody was used as a control.
- The hallmarks of the disease are fibrosis and infiltration by IgG4 secreting plasma cells.
- IgG4-related disease is a more recently identified cause of aortitis and periaortitis.
- Unlike the related clone TGN1112, an IgG1, TGN1412 is of the subclass IgG4.
- The technology modifies the human IgG4 antibody.
- Some of these deficiencies are also involved with pancreatitis and have been linked to IgG4 levels.
- IgG subclass deficiencies are sometimes correlated with bad responses to pneumoccal polyscaccharides, especially IgG2 and or IgG4 deficiency.
- These deficiencies can affect only one subclass or involve an association of two subclasses, such as IgG2 and IgG4.
- Immunoassay tests like ELISA that monitoring for increases in IgG4 antibodies can indicate tissue invasion by " Oesophagostomum ".
- Similar cases of granulomatous mastitis were reported in IgG4-related disease though the exact relationship to IGM remains to be elucidated.
- Treatment is recommended in all symptomatic cases of IgG4-RD and also in asymptomatic IgG4-RD involving certain anatomical sites.
- Treatment is recommended in all symptomatic cases of IgG4-RD and also in asymptomatic IgG4-RD involving certain anatomical sites.
- It has also been speculated that ligneous conjunctivitis may be a manifestation of IgG4-related disease ( IgG4-RD ).
- It has also been speculated that ligneous conjunctivitis may be a manifestation of IgG4-related disease ( IgG4-RD ).
- In solid tumors the use of CD279 IgG4 Ab is promising, and further CD273 / PD-L2 in stage IV.
- Radiologic evidence suggestive of involvement of the superior vena cava and seminal vesicle has been reported in confirmed cases of IgG4-RD.
- ตัวอย่างการใช้เพิ่มเติม: 1 2 3